Skip to main content

Shaibu plots to succeed Obaseki in 2024 — Ebea

The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-
Former deputy Speaker of the Edo State House of Assembly, Festus Ebea, called on the people of Edo Central Senatorial District to vote for the APC candidate in the forth coming governorship election.

 He said contrary to promises being made by Governor Godwin Obaseki, his deputy, Comrade Philip Shaibu, is surely having a plot to takes over from his boss in 2024.

He said voting for Pastor Osagie Ize-Iyamu was the best bet for Edo Central to have a shot at the governorship seat.

In a chat with Vanguard, Ebea alleged that if Obaseki wins his second term, he would hand over to Shaibu in their third year and then proceed to the Senate and pave the way for Shaibu to begin a fresh term in 2024.

Ebea said: “I remember in 2012 when we were celebrating the victory of Comrade Adams Oshiomhole’s second term re-election. We, as colleagues, we were just so joyous and out of excitement he (Shaibu) said after Comrade, the next person that will take over from him will certainly hand over to him.

“And when you see the events playing out, especially within the executive sphere of Edo State, you will find out that the relationship that now exists between the Governor and Deputy Governor, is not borne out of anything other than to respect the wish of Philip Shaibu."

He described Ebea’s comments on the 2024 governorship election as sickening and unacceptable.

Shaibu: “My destiny is in the hands of God and it is only God that can determine the future. I don’t know the next position that God is taking me.I am not like Ebea that brags on his ability. I brag on God’s ability, which is my driving force. He should speak about himself. He should not speak for me.”

Former Deputy Speaker of the Edo State House of Assembly, Festus Ebea, on Tuesday, called on the people of Edo Central Senatorial District to vote for All Progressives Congress, APC, and its candidate in the September 19 governorship election, saying contrary to promises being made by Governor Godwin Obaseki, his deputy, Comrade Philip Shaibu, is actually plotting to ensure he takes over from his boss in 2024.results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/

Comments

Popular posts from this blog

937 People Killed In Attacks In Kaduna In 2020

At least 937 people died in violent attacks and mass atrocities in Kaduna State last year, an annual security report by the state government has shown. The report released Wednesday attributed the deaths to kidnappings, banditry and other criminal activities that cut “across all ethnic and religious groups” in Kaduna State. “Victims of criminal acts like banditry and kidnapping are to be found across ethnic, religious or political leanings and persuasions,’’ Samuel Aruwan, the state’s commissioner for internal security and home affairs, said while presenting the report. In his presentation, Mr Aruwan said that of the 937 killed, Igabi Local Government Area recorded the highest number of casualties (152), followed by Kajuru Local Government Area with 144 casualties. He added that Birnin Gwari, Igabi, Giwa and Chikun local governments in Kaduna central accounted for about 50 per cent (or 468 deaths) of the entire fatalities in the state. Meanwhile, 286 died in Kaduna South from the viole...

Buhari Refuses To Act On Magu’s Probe Report Five Months After Submission.

President muhammedu Buhari Refuses To Act On Magu’s Probe Report Five Months After Submission One of Magu’s lawyers, Tosin Ojaomo, said Magu remained in the service of the Nigeria Police Force though the police has yet to post him anywhere after his suspension as EFCC chairman. Ibrahim Magu’s fate remains uncertain five months after the submission of the report of the Justice Ayo Salami Judicial Panel of Inquiry on the former acting chairman of the Economic and Financial Crimes Commission to President Muhammadu Buhari. There have been concerns about the fate of Magu after the appointment and confirmation of Abdulrasheed Bawa as the new Executive Chairman of EFCC in February. Although sources in the office of the Attorney General of the Federation and Minister of Justice, Abubakar Malami (SAN), said the panel faulted some procedures in the management of recovered assets under Magu, the presidential white paper on the report had yet to be announced. One of Magu’s lawyers, Tosin Ojaomo, s...

$114.28m COVID-19 loan: SERAP asks World Bank to make Nigeria ‘publicly commit to transparency’

Socio-Economic Rights and Accountability Project, (SERAP) has sent an open letter to the World Bank President Mr David Malpass, urging him to use his “good offices to encourage the Federal Government and 36 state governments to publicly commit to transparency and accountability in the spending of the $114.28m credit and grant for COVID-19, which the Bank’s Board of Directors recently approved for Nigeria, including by publishing details on a dedicated websit". SERAP also urged Mr Malpass to “put pressure on authorities and the 36 state governors to accept voluntary scrutiny by Nigerians and civil society regarding the spending of the funds and use of the resources, including on how they will spend the money to buy medical equipment, and improve access to clean water, sanitation and hygiene" The World Bank Board of Directors last Friday approved a $114.28 financing “to help Nigeria prevent, detect and respond to the threat posed by COVID-19 with a specific focus on state level...